HAYA Therapeutics is a Swiss-based pre-clinical early stage biopharmaceutical company dedicated to treating fibrotic diseases through the discovery and development of innovative targeted first-in-class RNA-based therapeutics, with a specific focus on long noncoding RNAs. Our vision is to be the first company and a world leader in translating long noncoding RNA discoveries into breakthrough therapies to monitor and treat patients with debilitating diseases caused by fibrosis.
HAYA Therapeutics SA Address
StartLab, Route De La Corniche 5 Lausanne/Epalinges, null